tiprankstipranks
Trending News
More News >
Cannomed Medical Cannabis Industries Ltd. (IL:GEFR)
:GEFR
Israel Market

Cannomed (GEFR) Income Statement

Compare
0 Followers

Cannomed Income Statement

Last quarter (Q3 2024), Cannomed's total revenue was 35.00K, a decrease of -1.41% from the same quarter last year. In Q3, Cannomed's net income was -1.02M. See Cannomed’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
142.00K 60.00K 658.00K 17.92M 0.00
Gross Profit
142.00K -5.93M -10.22M 4.83M -283.00K
Operating Expenses
6.92M 4.32M 5.45M 9.92M 6.77M
Depreciation and Amortization
518.00K 2.14M 1.96M 605.00K 410.00K
EBITDA
-6.11M -16.48M -18.18M -5.29M -1.56M
Operating Income
-6.78M -18.88M -20.16M -9.60M -6.69M
Other Income/Expenses
111.00K -146.00K -894.00K -1.41M -7.62M
Pretax Income
-6.67M -19.02M -21.05M -11.15M -9.38M
Net Income
-6.91M -20.08M -13.43M -8.81M -9.38M
Per Share Metrics
Basic EPS
-0.03 -0.20 -0.15 -0.35 -1.03
Diluted EPS
-0.03 -0.20 -0.15 -0.35 -1.03
Weighted Average Shares Outstanding
251.19M 99.39M 88.04M 24.93M 9.14M
Weighted Average Shares Outstanding (Diluted)
215.64M 99.39M 88.04M 24.93M 9.14M
Currency in ILS

Cannomed Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis